Capricor Therapeutics, Inc. (NASDAQ:CAPR) Q1 2025 Earnings Call Transcript May 13, 2025
Capricor Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.53 EPS, expectations were $-0.33.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Capricor Therapeutics First Quarter 2025 Earnings Call. At this time, all participant lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call...
